|
1.
|
|
5.0 MB |
Infecciones relacionadas con la asistencia sanitaria durante el empleo de dispositivos de asistencia cardiorrespiratoria Etiología, incidencia, factores predisponenentes y morbi-mortalidad
/
Gimeno Costa, José Ricardo ;
Álvarez Lerma, F., dir. ;
Pedro-Botet, Juan, dir.
L'ús de l'ECMO per a suport circulatori i/o respiratori ha augmentat els darrers anys. Aquest procediment és complex i no està exempt de complicacions, entre elles, les infeccions nosocomials (IN) relacionades amb es seu ús (INRECMO): les que tenen lloc a partir de les 48 hores de l'inici de l'assistència extracorpòria i fins 48 hores després de la seva retirada. [...]
El empleo del ECMO ha ido aumentando en los últimos años. Este procedimiento es complejo y tiene complicaciones, entre ellas, las infecciones nosocomiales (IN) relacionadas con su uso (INRECMO): las que tienen lugar a partir de las 48 horas del inicio de la asistencia extracorpórea y hasta 48 horas después de su retirada. [...]
The use of the ECMO for circulatory and/or respiratory support has been increasing in the recent years. This procedure is complex and is not exempt from complications, including the development of nosocomial infections (IN) related to the use of the ECMO therapy (INRECMO): those that occur 48 hours after the start of the extracorporeal assistance and up to 48 hours after its withdrawal. [...]
2023
|
|
|
2.
|
|
21.2 MB |
Evaluación del impacto en la mortalidad en UCI del tratamiento antiviral y coadyuvante con corticosteroides en pacientes con gripe grave y COVID-19
/
Moreno Muñoz, Gerard ;
Rodríguez Oviedo, Alejandro Hugo, dir. ;
Díaz Santos, Emilio, dir. ;
Álvarez Lerma, F., dir.
La grip i la COVID-19, malalties infeccioses causades pels virus respiratoris influenza i SARS-CoV-2, són un problema major de salut pública a nivell mundial ja que han estat responsables de pandèmies catastròfiques per a la humanitat al llarg de la història i comporten una gran morbimortalitat, especialment en aquells pacients que ingressen a la unitat de cures intensives (UCI) amb pneumònia viral. [...]
La gripe y la COVID-19, enfermedades infecciosas causadas por los virus respiratorios influenza y SARS-CoV-2, son un problema mayor de salud pública a nivel mundial ya que han sido responsables de pandemias catastróficas para la humanidad a lo largo de la historia y conllevan una gran morbimortalidad, especialmente en aquellos pacientes que ingresan en la unidad de cuidados intensivos (UCI) con neumonía viral. [...]
Flu and COVID-19, infectious diseases caused by influenza and SARS-CoV-2 respiratory virus, are a major public health problem worldwide due to their capacity of developing catastrophic pandemics for humanity thorough history leading to significant morbimortality, especially in those patients who need intensive care unit (ICU) admission due to viral pneumonia. [...]
2022
|
|
|
3.
|
|
11 p, 633.9 KB |
Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome
/
Álvarez Lerma, Francisco (Universitat Autònoma de Barcelona. Departament de Medicina) ;
Marin-Corral, Judith (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Vila, Clara (Hospital del Mar (Barcelona, Catalunya)) ;
Masclans, Joan Ramón (Hospital del Mar (Barcelona, Catalunya)) ;
González de Molina, Francisco Javier (Hospital Universitari MútuaTerrassa (Terrassa, Catalunya)) ;
Martín Loeches, Ignacio (Service of Intensive Care Medicine, St James Hospital, Dublin, Ireland) ;
Barbadillo, Sandra (Hospital General de Catalunya (Sant Cugat del Vallès, Catalunya)) ;
Rodríguez, Alejandro (Hospital Universitari Joan XXIII de Tarragona)
Patients infected with influenza A (H1N1)pdm09 virus requiring admission to the ICU remain an important source of mortality during the influenza season. The objective of the study was to assess the impact of a delay in diagnosis of community-acquired influenza A (H1N1)pdm09 virus infection on clinical outcome in critically ill patients admitted to the ICU. [...]
2016 -  10.1186/s13054-016-1512-1
Critical Care, Vol. 20 (october 2016)
|
|
|
4.
|
|
5 p, 732.0 KB |
Intensive care unit patients with lower respiratory tract nosocomial infections : the ENIRRIs project
/
De Pascale, Gennaro (Università Cattolica del Sacro Cuore) ;
Ranzani, Otavio T. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Nseir, Saad (CHU Lille) ;
Chastre, Jean (Groupe Hospitalier Pitié-Salpêtrière) ;
Welte, Tobias (Hannover Medical School) ;
Antonelli, Massimo (Università Cattolica del Sacro Cuore) ;
Navalesi, Paolo (Università della Magna Graecia) ;
Garofalo, Eugenio (Università della Magna Graecia) ;
Bruni, Andrea (Università della Magna Graecia) ;
Coelho, Luis (New University of Lisbon) ;
Skoczynski, Szymon (Medical University of Silesia) ;
Longhini, Federico (Sant'Andrea Hospital) ;
Taccone, Fabio Silvio (Université Libre de Bruxelles) ;
Grimaldi, David (Université Libre de Bruxelles) ;
Salzer, Helmut J. F. (University of Lübeck) ;
Lange, Christoph (University of Lübeck) ;
Froes, Filipe (Hospital Pulido Valente) ;
Artigas Raventós, Antoni (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Díaz-Aparicio, Efren (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Vallés, Jordi (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Rodríguez, Alejandro (Hospital Universitari Joan XXIII de Tarragona) ;
Panigada, Mauro (Ospedale Maggiore Policlinico) ;
Comellini, Vittoria (Alma Mater University) ;
Fasano, Luca (Alma Mater University) ;
Soave, Paolo M. (Università Cattolica del Sacro Cuore) ;
Spinazzola, Giorgia (Università Cattolica del Sacro Cuore) ;
Luyt, Charles-Edouard (Groupe Hospitalier Pitié-Salpêtrière) ;
Álvarez Lerma, Francisco (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Marin, Judith (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Masclans, Joan R (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Chiumello, Davide (Università degli Studi di Milano) ;
Pezzi, Angelo (Università degli Studi di Milano) ;
Schultz, Marcus (Mahidol University) ;
Mohamed, Hafiz (St. James's Hospital (Irlanda)) ;
Van Der Eerden, Menno (Erasmus MC (Rotterdam)) ;
Hoek, Roger A. S. (Erasmus MC (Rotterdam)) ;
Gommers, D. A. M. P. J. (Erasmus MC (Rotterdam)) ;
Pasquale, Marta Di (IRCCS Fondazione Cà Granda Ospedale Maggiore Policlinico) ;
Civljak, Rok (University of Zagreb School of Medicine) ;
Kutleša, Marko (University of Zagreb School of Medicine) ;
Bassetti, Matteo (Medicine University of Udine and Santa aria Misericordia Hospital) ;
Dimopoulos, George (University General Hospital Attikon (Haidari, Grècia)) ;
Nava, Stefano (Alma Mater University) ;
Rios, Fernando (Hospital Nacional Profesor A Posadas (Argentina)) ;
Zampieri, Fernando G. (Hospital do Coração (Brasil)) ;
Povoa, Pedro (New University of Lisbon) ;
Bos, Lieuwe D.. (Academic Medical Center (Holanda)) ;
Aliberti, Stefano (IRCCS Fondazione Cà Granda Ospedale Maggiore Policlinico) ;
Torres, Antoni (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Martín-Loeches, Ignacio (St. James's Hospital (Irlanda)) ;
Universitat Autònoma de Barcelona
The clinical course of intensive care unit (ICU) patients may be complicated by a large spectrum of lower respiratory tract infections (LRTI), defined by specific epidemiological, clinical and microbiological aspects. [...]
2017 - 10.1183/23120541.00092-2017
ERJ Open Research, Vol. 3 (november 2017)
|
|
|
5.
|
|
201 p, 9.4 MB |
Relevancia clínica de la monitorización de niveles de Linezolid en el paciente crítico
/
Muñoz Bermúdez, Rosana ;
Álvarez Lerma, Francisco, dir. ;
Grau, Santiago, dir. ;
Pedro-Botet, Juan, dir.
Linezolid és un antibiòtic ampliament utilitzat en pacients crítics pel tractament d'infeccions en les que es coneix o se sospita la presència de cocos Gram positius (CGP) resistents a meticil·lina o vancomicina. [...]
Linezolid es un antibiótico ampliamente utilizado en pacientes críticos para el tratamiento de infecciones en las que se conoce o se sospecha la presencia de cocos Gram positivos (CGP) resistentes a meticilina o vancomicina. [...]
Linezolid is an antibiotic widely used in critically ill patients for the treatment of infections in which the presence of Gram-positive cocci (PGC) resistant to methicillin or vancomycin is known or suspected. [...]
2021
|
|
|
6.
|
|
11 p, 838.8 KB |
Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia : a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)
/
Welte, Tobias (Carl-Neuberg-Str. 1, 30625 Hannover, Germany) ;
Dellinger, R. Phillip (Cooper Medical School of Rowan University. Department of Medicine) ;
Ebelt, Henning (Universitätsklinikum Halle (Saale). Klinik und Poliklinik für Innere Medizin III) ;
Ferrer, Miguel (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Opal, Steven M. (Rhode Island Hospital. Infectious Disease Division) ;
Singer, Mervyn (University College London. Bloomsbury Institute of Intensive Care Medicine) ;
Vincent, Jean-Louis (Erasme University Hospital. Department of Intensive Care) ;
Werdan, Karl (St. James's Hospital. Trinity Centre for Health Sciences) ;
Martin-Loeches, Ignacio (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Almirall i Pujol, Jordi (Hospital de Mataró. Consorci Sanitari del Maresme) ;
Artigas Raventós, Antoni (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Ignacio Ayestarán, Jose (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ;
Nuding, Sebastian (Hospital Universitari MútuaTerrassa (Terrassa, Catalunya)) ;
Ferrer, Ricard (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Sirgo Rodríguez, Gonzalo (Hospital Universitari Joan XXIII de Tarragona) ;
Shankar-Hari, Manu (Guy's and St. Thomas' NHS Foundation Trust. Intensive Care Medicine) ;
Álvarez Lerma, Francisco (Hospital del Mar (Barcelona, Catalunya)) ;
Riessen, Reimer (Universitätsklinikum Tübingen. Internistische Intensivstation) ;
Sirvent, Josep-Maria (Hospital Universitari de Girona Doctor Josep Trueta) ;
Kluge, Stefan (Universitätsklinikum Hamburg-Eppendorf. Klinik für Intensivmedizin) ;
Zacharowski, Kai (Universitätsklinikum Frankfurt. Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie) ;
Bonastre Mora, Juan (Hospital Universitari i Politècnic La Fe (València)) ;
Lapp, Harald (Medizinische Klinik, Kardiologie und Intensivmedizin, Helios Klinikum Erfurt, Erfurt, Germany) ;
Wöbker, Gabriele (Klinik für Intensivmedizin, Helios Universitätsklinikum Wuppertal, Wuppertal, Germany) ;
Achtzehn, Ute (Klinikum Chemnitz gGmbH. Innere Medizin IV - Pneumologie) ;
Brealey, David (Critical Care Unit, NIHR University College London Hospitals Biomedical Research Centre, University College London Hospitals, NHS Foundation Trust, London, UK) ;
Kempa, Axel (Katharinenhospital, Stuttgart. Klinik für Allgemeine Innere Medizin) ;
Sánchez García, Miguel (Hospital Clínico San Carlos (Madrid)) ;
Brederlau, Jörg (Helios Klinikum Berlin-Buch, Klinik für Intensivmedizin) ;
Kochanek, Matthias (University Hospital of Cologne. Department I of Internal Medicine) ;
Reschreiter, Henrik Peer (Poole Hospital NHS Foundation Trust) ;
Wise, Matthew P. (Heath Park, Cardiff) ;
Belohradsky, Bernd H. (University Children's Hospital Munich) ;
Bobenhausen, Iris (Biotest AG) ;
Dälken, Benjamin (Biotest AG) ;
Dubovy, Patrick (Biotest AG) ;
Langohr, Patrick (Biotest AG) ;
Mayer, Monika (Biotest AG) ;
Schüttrumpf, Jörg (Biotest AG) ;
Wartenberg-Demand, Andrea (Biotest AG) ;
Wippermann, Ulrike (Biotest AG) ;
Wolf, Daniele (Biotest AG) ;
Torres, Antoni (Hospital Clínic i Provincial de Barcelona)
The CIGMA study investigated a novel human polyclonal antibody preparation (trimodulin) containing ~ 23% immunoglobulin (Ig) M, ~ 21% IgA, and ~ 56% IgG as add-on therapy for patients with severe community-acquired pneumonia (sCAP). [...]
2018 - 10.1007/s00134-018-5143-7
Intensive Care Medicine, Vol. 44 (april 2018) , p. 438-448
|
|
|
7.
|
|
|
8.
|
|
8 p, 202.9 KB |
Prevention of Ventilator-Associated Pneumonia : The Multimodal Approach of the Spanish ICU "Pneumonia Zero" Program*
/
Álvarez Lerma, Francisco (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Palomar Martínez, Mercedes (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Sánchez-García, Miguel (Hospital Clínico San Carlos (Madrid)) ;
Martínez-Alonso, Montserrat ;
Álvarez-Rodríguez, Joaquín (Service of Intensive Care Medicine, SEMICYUC Working Group on Safety, Quality and Management, Hospital de Fuenlabrada, Fuenlabrada, Madrid, Spain) ;
Lorente, Leonardo (Hospital Universitario de Canarias (La Laguna)) ;
Arias-Rivera, Susana (Hospital Universitario de Getafe (Madrid)) ;
Garcia, Rosa (Hospital de Basurto (Bilbao, Biscaia)) ;
Gordo, Federico (Hospital Universitario del Henares ( Madrid)) ;
Añón, José Manuel (Instituto de Investigación Sanitaria del Hospital Universitario La Paz) ;
Jam-Gatell, Rosa (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Vázquez-Calatayud, Mónica (Clínica Universidad de Navarra) ;
Agra Varela, Yolanda (Patient Safety Unit, Spanish Ministry of Health, Social Policy and Equality, Madrid, Spain) ;
Universitat Autònoma de Barcelona
Supplemental Digital Content is available in the text. The "Pneumonia Zero" project is a nationwide multimodal intervention based on the simultaneous implementation of a comprehensive evidence-based bundle measures to prevent ventilator-associated pneumonia in critically ill patients admitted to the ICU. [...]
2018 - 10.1097/CCM.0000000000002736
Critical Care Medicine, Vol. 46 (january 2018) , p. 181-188
|
|
|
9.
|
|
9 p, 446.3 KB |
Impact of colistin plasma levels on the clinical outcome of patients with infections caused by extremely drug-resistant Pseudomonas aeruginosa
/
Sorlí, Luisa (Universitat Autònoma de Barcelona) ;
Luque, Sonia (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Segura, Concepción (Laboratori de Referència de Catalunya (El Prat de Llobregat, Catalunya)) ;
Campillo, Núria (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Montero, Milagro (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias) ;
Esteve, Erika (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Herrera, Sabina (Institut Hospital del Mar d'Investigacions Mèdiques) ;
Benito, Natividad (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias) ;
Álvarez Lerma, Francisco (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias) ;
Grau, Santiago (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias) ;
Horcajada, Juan Pablo (Universitat Autònoma de Barcelona)
Colistin has a narrow therapeutic window with nephrotoxicity being the major dose-limiting adverse effect. Currently, the optimal doses and therapeutic plasma levels are unknown. Prospective observational cohort study, including patients infected by colistin-susceptible P. [...]
2017 - 10.1186/s12879-016-2117-7
BMC Infectious diseases, Vol. 17 (january 2017)
|
|
|
10.
|
|
11 p, 762.2 KB |
Multiple time scales in modeling the incidence of infections acquired in intensive care units
/
Wolkewitz, Martin (Freiburg Center of Data Analysis and Modelling, Albert-Ludwigs University Freiburg, Freiburg, Germany) ;
Cooper, Ben S. (University of Oxford. Centre for Tropical Medicine and Global Health) ;
Palomar Martínez, Mercedes (Hospital Arnau de Vilanova (Lleida, Catalunya)) ;
Álvarez Lerma, Francisco (Parc de Salut MAR de Barcelona) ;
Olaechea-Astigarraga, Pedro (Hospital de Galdakao (Usansolo, Biscaia)) ;
Barnett, Adrian G. (Institute of Health and Biomedical Innovation and School of Public Health and Social Work, Queensland University of Technology, Brisbane QLD, 4059 Australia) ;
Schumacher, Martin (Institute for Medical Biometry and Statistics, Faculty of Medicine and Medical Center - University of Freiburg, Freiburg, Germany) ;
Universitat Autònoma de Barcelona
When patients are admitted to an intensive care unit (ICU) their risk of getting an infection will be highly depend on the length of stay at-risk in the ICU. In addition, risk of infection is likely to vary over calendar time as a result of fluctuations in the prevalence of the pathogen on the ward. [...]
2016 - 10.1186/s12874-016-0199-y
BMC Medical Research Methodology, Vol. 16 (september 2016)
|
|
visitante ::
identificación
alerta personal vía correo electrónico o subscríbase al 
canal RSS.
